Startup Offers Comprehensive Personalized Genome Sequencing For a Hefty Price | GenomeWeb
This article has been updated to include comment from Knome CEO Jorge Conde.
 
NEW YORK (GenomeWeb News) – With the personal genomics market accelerating in recent weeks after three companies launched individual genotyping services for blue-plate prices, Cambridge, Mass.-based Knome raised the stakes by offering whole-genome sequencing direct to consumers – sort of.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.